Company: ASAN
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001477720-25-000081
Chunk: 27

Company: Asana, Inc.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 27
---
 Asana 2025 Proxy Statement23

#### Board of Directors and Corporate Governance
Class A common stock on the grant date. With respect to deferral elections made under our Deferred Compensation Plan, which allows for the accumulation of fractional shares, the right to receive shares of our Class A common stock equal to the difference in value between $175,000 and the grant date fair value was credited to the stock unit account for Ms. Norrington. The assumptions used in calculating the grant date fair value of the stock awards reported in this column are set forth in the notes to our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2025. This amount does not reflect the actual economic value that may be realized by the non-employee director.

(3) As of January 31, 2025, Ms. Anderson-Copperman’s outstanding equity awards consisted of: (a) 6,555 shares of our Class A common stock subject to unvested RSUs that will vest (i) in equal annual installments over a three-year period such that the grant will be fully vested on the third anniversary of the date of grant or (ii) in full upon a Change in Control (as defined in the Company’s 2020 Equity Incentive Plan), in either case, subject to her continuous service through the applicable vesting date and, upon vesting, the shares will be subject to the Director Initial Grant Holding Period; (b) 13,108 shares of our Class A common stock subject to vested RSUs that remain subject to the Director Initial Grant Holding Period and therefore have not yet been delivered to Ms. Anderson-Copperman; and (c) 14,583 shares of our Class A common stock subject to unvested RSUs that will vest (i) on the first anniversary of the date of grant or (ii) upon a Change in Control (as defined in the Company’s 2020 Equity Incentive Plan), in either case, subject to her continuous service through the applicable vesting date.

(4) As of January 31, 2025, Ms. Carey's outstanding equity awards consisted of: (a) 9,684 shares of our Class A common stock subject to vested RSUs that remain subject to the Director Annual Grant Holding Period and therefore have not yet been delivered to Ms. Carey; and (b) 14,583 shares of our Class A common stock subject to unvested RS